Austin cancer-fighting biotech Mirna Therapeutics to fold after reverse merger

Mirna Therapeutics Inc., after raising tens of millions of dollars in venture capital and research grants and going public, has reached the end of the road.
The Austin-based biotech company halted drug development last year following deaths of patients in clinical trials— now it is being acquired by a Boston-area suitor in a reverse merger.
Synlogic Inc. of Cambridge, Massachusetts, which focuses on drugs that affect bacteria in the gut, announced Tuesday its merger with Mirna (Nasdaq: MIRN),…

#URLinkedUp Austin Business News – Local Austin News | Austin Business Journal

#Austin Check out URLinkedUp >


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s